Lachelle Dawn Weeks

24PUBLICATIONS
153CO-AUTHORS
HaematologyCancer geneticsPharmacogenomicsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 29, 2026
Characteristics of Donor and Recipient Clonal Hematopoiesis in Nonmyeloablative Transplant for Sickle Cell Disease.

|Apr 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.

|Feb 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.

David B Beck, Maël Heiblig, Sinisa Savic

|Feb 26, 2026
Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicing.

Jonas S Jutzi, Edie Crosse, Chulwoo J Kim

|Feb 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.

Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson

|Nov 25, 2025
Establishing a consensus definition of VEXAS flare for clinical research.

Lachelle D Weeks, Danielle Hammond, Sinisa Savic

Pageof 4

Frequent Collaborators

5 joint publications

Marlise R Luskin

4 joint publications

Benjamin L Ebert

3 joint publications

Alfred Ian Lee

3 joint publications

Catherine R Marinac